Affinity of alkylphosphocholines to biological membrane of prostate cancer : studies in natural and model systems

2014
journal article
article
14
cris.lastimport.wos2024-04-10T02:11:09Z
dc.abstract.enThe effectiveness of two alkylphosphocholines (APCs), hexadecylphosphocholine (miltefosine) and erucylphosphocholine to combat prostate cancer has been studied in vitro with artificial cancerous membrane, modelled with the Langmuir monolayer technique, and on cell line (Du-145). Studies performed with the Langmuir method indicate that both the investigated drugs have the affinity to the monolayer mimicking prostate cancer membrane (composed of cholesterol:POPC = 0.428) and the drug-membrane interactions are stronger for erucylphosphocholine as compared to hexadecylphosphocholine. Moreover, both studied drugs were found to fluidize the model membrane, which may lead to apoptosis. Indeed, biological studies confirmed that in Du-145 cell line both investigated alkylphosphocholines cause cell death primarily by apoptosis while necrotic cells constitute only a small percentage of APC-treated cells.pl
dc.affiliationWydział Chemii : Zakład Chemii Ogólnejpl
dc.affiliationWydział Fizyki, Astronomii i Informatyki Stosowanej : Instytut Fizyki im. Mariana Smoluchowskiegopl
dc.contributor.authorWnętrzak, Anita - 157862 pl
dc.contributor.authorLipiec, Ewelinapl
dc.contributor.authorŁątka, Kazimierz - 100050 pl
dc.contributor.authorKwiatek, Wojciechpl
dc.contributor.authorDynarowicz-Łątka, Patrycja - 127845 pl
dc.date.accession2019-03-11pl
dc.date.accessioned2015-05-27T08:36:49Z
dc.date.available2015-05-27T08:36:49Z
dc.date.issued2014pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.number7pl
dc.description.physical581-589pl
dc.description.publication0,5pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume247pl
dc.identifier.doi10.1007/s00232-014-9674-8pl
dc.identifier.eissn1432-1424pl
dc.identifier.issn0022-2631pl
dc.identifier.projectROD UJ / Ppl
dc.identifier.urihttp://ruj.uj.edu.pl/xmlui/handle/item/8181
dc.identifier.weblinkhttps://link.springer.com/content/pdf/10.1007%2Fs00232-014-9674-8.pdfpl
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa*
dc.rights.licenceCC-BY
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/legalcode.pl*
dc.share.typeinne
dc.subject.enalkylphosphocholinespl
dc.subject.enmodel membranepl
dc.subject.enLangmuir monolayerspl
dc.subject.enprostate cancerpl
dc.subtypeArticlepl
dc.titleAffinity of alkylphosphocholines to biological membrane of prostate cancer : studies in natural and model systemspl
dc.title.journalThe Journal of Membrane Biologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-10T02:11:09Z
dc.abstract.enpl
The effectiveness of two alkylphosphocholines (APCs), hexadecylphosphocholine (miltefosine) and erucylphosphocholine to combat prostate cancer has been studied in vitro with artificial cancerous membrane, modelled with the Langmuir monolayer technique, and on cell line (Du-145). Studies performed with the Langmuir method indicate that both the investigated drugs have the affinity to the monolayer mimicking prostate cancer membrane (composed of cholesterol:POPC = 0.428) and the drug-membrane interactions are stronger for erucylphosphocholine as compared to hexadecylphosphocholine. Moreover, both studied drugs were found to fluidize the model membrane, which may lead to apoptosis. Indeed, biological studies confirmed that in Du-145 cell line both investigated alkylphosphocholines cause cell death primarily by apoptosis while necrotic cells constitute only a small percentage of APC-treated cells.
dc.affiliationpl
Wydział Chemii : Zakład Chemii Ogólnej
dc.affiliationpl
Wydział Fizyki, Astronomii i Informatyki Stosowanej : Instytut Fizyki im. Mariana Smoluchowskiego
dc.contributor.authorpl
Wnętrzak, Anita - 157862
dc.contributor.authorpl
Lipiec, Ewelina
dc.contributor.authorpl
Łątka, Kazimierz - 100050
dc.contributor.authorpl
Kwiatek, Wojciech
dc.contributor.authorpl
Dynarowicz-Łątka, Patrycja - 127845
dc.date.accessionpl
2019-03-11
dc.date.accessioned
2015-05-27T08:36:49Z
dc.date.available
2015-05-27T08:36:49Z
dc.date.issuedpl
2014
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.numberpl
7
dc.description.physicalpl
581-589
dc.description.publicationpl
0,5
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
247
dc.identifier.doipl
10.1007/s00232-014-9674-8
dc.identifier.eissnpl
1432-1424
dc.identifier.issnpl
0022-2631
dc.identifier.projectpl
ROD UJ / P
dc.identifier.uri
http://ruj.uj.edu.pl/xmlui/handle/item/8181
dc.identifier.weblinkpl
https://link.springer.com/content/pdf/10.1007%2Fs00232-014-9674-8.pdf
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa 4.0 Międzynarodowa
dc.rights.licence
CC-BY
dc.rights.uri*
http://creativecommons.org/licenses/by/4.0/legalcode.pl
dc.share.type
inne
dc.subject.enpl
alkylphosphocholines
dc.subject.enpl
model membrane
dc.subject.enpl
Langmuir monolayers
dc.subject.enpl
prostate cancer
dc.subtypepl
Article
dc.titlepl
Affinity of alkylphosphocholines to biological membrane of prostate cancer : studies in natural and model systems
dc.title.journalpl
The Journal of Membrane Biology
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.